NATERA, INC. Revenue
NATERA, INC. (NTRA) reported Revenue of $752.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-07
- NATERA, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $752.75M, a 37.71% increase year-over-year.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $696.64M, a 38.82% increase year-over-year.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $665.50M, a 39.79% increase year-over-year.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $592.18M, a 34.66% increase year-over-year.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $2.31B, a 35.90% increase from fiscal 2024.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.70B, a 56.75% increase from fiscal 2023.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.08B, a 31.99% increase from fiscal 2022.
- NATERA, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $820.22M, a 31.13% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $752.75M 10-Q · filed 2026-08-07 | $1.45B 10-Q · filed 2026-08-07 | $2.11B derived: sum of 3 quarters · filed 2026-08-07 | $2.71B derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $696.64M 10-Q · filed 2026-05-08 | $1.36B derived: sum of 2 quarters · filed 2026-05-08 | $1.95B derived: sum of 3 quarters · filed 2026-05-08 | $2.50B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $665.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.26B derived: sum of 2 quarters · filed 2026-02-27 | $1.80B derived: sum of 3 quarters · filed 2026-08-07 | $2.31B 10-K · filed 2026-02-27 |
| 2025-09-30 | $592.18M 10-Q · filed 2025-11-07 | $1.14B derived: sum of 2 quarters · filed 2026-08-07 | $1.64B 10-Q · filed 2025-11-07 | $2.12B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $546.60M 10-Q · filed 2026-08-07 | $1.05B 10-Q · filed 2026-08-07 | $1.52B derived: sum of 3 quarters · filed 2026-08-07 | $1.96B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $501.83M 10-Q · filed 2026-05-08 | $977.89M derived: sum of 2 quarters · filed 2026-05-08 | $1.42B derived: sum of 3 quarters · filed 2026-05-08 | $1.83B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $476.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $915.82M derived: sum of 2 quarters · filed 2026-02-27 | $1.33B derived: sum of 3 quarters · filed 2026-02-27 | $1.70B 10-K · filed 2026-02-27 |
| 2024-09-30 | $439.76M 10-Q · filed 2025-11-07 | $853.11M derived: sum of 2 quarters · filed 2025-11-07 | $1.22B 10-Q · filed 2025-11-07 | $1.53B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $413.35M 10-Q · filed 2025-08-08 | $781.09M 10-Q · filed 2025-08-08 | $1.09B derived: sum of 3 quarters · filed 2026-02-27 | $1.36B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $367.74M 10-Q · filed 2025-05-09 | $678.85M derived: sum of 2 quarters · filed 2026-02-27 | $947.15M derived: sum of 3 quarters · filed 2026-02-27 | $1.21B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $311.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $579.41M derived: sum of 2 quarters · filed 2026-02-27 | $840.82M derived: sum of 3 quarters · filed 2026-02-27 | $1.08B 10-K · filed 2026-02-27 |
| 2023-09-30 | $268.31M 10-Q · filed 2024-11-12 | $529.71M derived: sum of 2 quarters · filed 2024-11-12 | $771.47M 10-Q · filed 2024-11-12 | $988.72M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $261.40M 10-Q · filed 2024-08-09 | $503.16M 10-Q · filed 2024-08-09 | $720.41M derived: sum of 3 quarters · filed 2025-02-28 | $931.05M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $241.76M 10-Q · filed 2024-05-10 | $459.01M derived: sum of 2 quarters · filed 2025-02-28 | $669.64M derived: sum of 3 quarters · filed 2025-02-28 | $867.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $217.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $427.89M derived: sum of 2 quarters · filed 2025-02-28 | $626.09M derived: sum of 3 quarters · filed 2025-02-28 | $820.22M 10-K · filed 2025-02-28 |
| 2022-09-30 | $210.64M 10-Q · filed 2023-11-09 | $408.84M derived: sum of 2 quarters · filed 2023-11-09 | $602.97M 10-Q · filed 2023-11-09 | $776.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $198.20M 10-Q · filed 2023-08-04 | $392.33M 10-Q · filed 2023-08-04 | $565.36M derived: sum of 3 quarters · filed 2024-02-29 | $723.48M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $194.13M 10-Q · filed 2023-05-10 | $367.16M derived: sum of 2 quarters · filed 2024-02-29 | $525.28M derived: sum of 3 quarters · filed 2024-02-29 | $667.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $173.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $331.14M derived: sum of 2 quarters · filed 2024-02-29 | $473.17M derived: sum of 3 quarters · filed 2024-02-29 | $625.49M 10-K · filed 2024-02-29 |
| 2021-09-30 | $158.12M 10-Q · filed 2022-11-09 | $300.14M derived: sum of 2 quarters · filed 2022-11-09 | $452.46M 10-Q · filed 2022-11-09 | $564.84M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $142.03M 10-Q · filed 2022-08-05 | $294.34M 10-Q · filed 2022-08-05 | $406.72M derived: sum of 3 quarters · filed 2023-03-01 | $504.86M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $152.32M 10-Q · filed 2022-05-06 | $264.69M derived: sum of 2 quarters · filed 2023-03-01 | $362.84M derived: sum of 3 quarters · filed 2023-03-01 | $449.31M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $112.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $210.52M derived: sum of 2 quarters · filed 2023-03-01 | $296.99M derived: sum of 3 quarters · filed 2023-03-01 | $391.00M 10-K · filed 2023-03-01 |
| 2020-09-30 | $98.14M 10-Q · filed 2021-11-05 | $184.62M derived: sum of 2 quarters · filed 2021-11-05 | $278.63M 10-Q · filed 2021-11-05 | $361.87M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $86.47M 10-Q · filed 2021-08-06 | $180.48M 10-Q · filed 2021-08-06 | $263.72M derived: sum of 3 quarters · filed 2021-08-06 | $341.63M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $94.01M 10-Q · filed 2021-05-07 | $177.25M derived: sum of 2 quarters · filed 2021-05-07 | $255.16M derived: sum of 3 quarters · filed 2021-05-07 | $329.52M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $83.24M 10-K · filed 2020-03-02 | $161.15M derived: sum of 2 quarters · filed 2020-11-06 | $235.50M derived: sum of 3 quarters · filed 2020-11-06 | $302.33M 10-K · filed 2022-02-25 |
| 2019-09-30 | $77.91M 10-Q · filed 2020-11-06 | $152.26M derived: sum of 2 quarters · filed 2020-11-06 | $219.09M 10-Q · filed 2020-11-06 | $286.05M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $74.36M 10-Q · filed 2020-08-07 | $141.18M 10-Q · filed 2020-08-07 | $208.14M derived: sum of 3 quarters · filed 2020-08-07 | $273.42M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $66.82M 10-Q · filed 2020-05-08 | $133.79M derived: sum of 2 quarters · filed 2020-05-08 | $199.07M derived: sum of 3 quarters · filed 2020-05-08 | $262.14M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $66.97M 10-K · filed 2020-03-02 | $132.25M derived: sum of 2 quarters · filed 2020-03-02 | $195.31M derived: sum of 3 quarters · filed 2020-03-02 | $257.65M 10-K · filed 2021-02-26 |
| 2018-09-30 | $65.28M 10-K · filed 2020-03-02 | $128.35M derived: sum of 2 quarters · filed 2020-03-02 | $190.69M 10-Q · filed 2019-11-08 | $242.74M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $63.07M 10-K · filed 2020-03-02 | $125.41M 10-Q · filed 2019-08-09 | $177.46M derived: sum of 3 quarters · filed 2020-03-02 | $233.37M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $62.34M 10-K · filed 2020-03-02 | $114.39M derived: sum of 2 quarters · filed 2020-03-02 | $170.30M derived: sum of 3 quarters · filed 2020-03-02 | $222.58M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $52.05M 10-K · filed 2019-03-15 | $107.96M derived: sum of 2 quarters · filed 2019-03-15 | $160.24M derived: sum of 3 quarters · filed 2019-03-15 | $209.63M 10-K · filed 2020-03-02 |
| 2017-09-30 | $55.91M 10-K · filed 2019-03-15 | $108.19M derived: sum of 2 quarters · filed 2019-03-15 | $157.57M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $52.28M 10-K · filed 2019-03-15 | $101.67M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $49.38M 10-K · filed 2019-03-15 | |||
| 2016-12-31 | $212.51M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |